← Browse by Condition
Medical Condition

resectable intrahepatic cholangiocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06050252 Phase 2
Recruiting

Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resectable Liver Cancer Before Surgery

Enrollment
27 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →